6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
15m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m ago	CPKC increases dividend by 17.5 percent
41m ago	Waldencast announces conclusion of SEC investigation
42m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Ocugen Inc (NASDAQ:OCGN) — investor relations, events, news, and company updates on 6ix.

Latest News

Ocugen to Present at April 2026 Investor and Industry Conferences

Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease

Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy

Ocugen Provides Business Update with Fourth Quarter and Full Year 2025 Financial Results

Financials

Revenue

$4.41 M

Market Cap

$586.94 M

EPS

-0.23

Community Chat

Ask AI